The Suspected Insulin Resistance panel is a diagnostic assessment that includes markers such as Glucose, Hemoglobin A1c (HbA1c), and Insulin. This panel is ordered to evaluate insulin resistance, a condition where the body's cells do not respond effectively to insulin, leading to elevated blood glucose levels. Insulin resistance is often associated with prediabetes, type 2 diabetes, and metabolic syndrome.

The Cardio IQ™ Insulin Resistance Panel with Score Test measures markers of insulin resistance to evaluate glucose control, lipid metabolism, and cardiometabolic health. The score offers insight into type 2 diabetes risk, cardiovascular disease, and endocrine balance. This test supports monitoring of metabolic function, energy regulation, and systemic conditions tied to insulin resistance.

The Insulin Response to Glucose Test, 7 Specimens evaluates insulin secretion and glucose regulation using fasting plus six post-glucose solution samples. With seven data points, the test highlights abnormalities in beta-cell activity, insulin resistance, and carbohydrate metabolism. Results provide valuable insight into how the body processes glucose and help identify metabolic dysfunction, prediabetes, or diabetes risk.

The Insulin Response to Glucose Test, 8 Specimens evaluates insulin secretion and glucose handling using fasting and seven post-glucose solution samples. This extended assessment highlights beta-cell activity, insulin resistance, and carbohydrate metabolism. Results reveal how efficiently the body processes glucose, supporting early detection of prediabetes, diabetes, or related metabolic disorders.

The Insulin Response to Glucose Test, 9 Specimens evaluates insulin secretion and glucose regulation through fasting plus eight post-glucose solution samples. This extended assessment highlights beta-cell performance, insulin resistance, and carbohydrate metabolism. Results provide insight into how the body processes glucose and support early detection of metabolic dysfunction, prediabetes, or diabetes risk.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The Insulin Response to Glucose Test, 2 Specimens evaluates insulin secretion by comparing fasting levels with those measured after drinking a glucose solution. This test helps identify impaired insulin sensitivity, abnormal glucose regulation, and early metabolic dysfunction. It provides valuable information on beta-cell function, carbohydrate metabolism, and risk of developing prediabetes or diabetes.

The Insulin Response to Glucose Test, 4 Specimens evaluates insulin secretion and glucose regulation using fasting and three post-glucose solution samples. This expanded view highlights beta-cell activity, insulin resistance, and abnormal carbohydrate metabolism. Results reveal how efficiently the body processes glucose and help identify metabolic dysfunction, prediabetes, and diabetes-related risks.

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The Insulin Autoantibody Test measures antibodies against insulin to evaluate autoimmune activity associated with type 1 diabetes. Insulin autoantibodies are often one of the first markers to appear, especially in children, signaling heightened risk for beta cell destruction. This test provides insight into early disease risk, helps confirm diagnosis, and supports assessment of immune-mediated diabetes.

The Insulin Response to Glucose Test, 6 Specimens evaluates insulin secretion and glucose regulation with fasting and five post-glucose solution samples. This comprehensive approach highlights beta-cell activity, insulin resistance, and abnormalities in carbohydrate metabolism. Results show how efficiently the body clears glucose, supporting early detection of metabolic dysfunction, prediabetes, and diabetes risk.